Peripheral Facial Paralysis
6
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Functional Recovery From Facial Paralysis
Clinical Study on the End Time of Acupuncture and Moxibustion Therapy for Peripheral Facial Paralysis
Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy
Lengthening Temporalis Myoplasty and Improvement of Primary Swallowing Disorders in Facial Paralysis
Validation of a French-language Version of Quality of Life Questionnaires in Patients With Peripheral Facial Palsy
Anthropometric Angular Measurement to Determine Muscle Tonus in Patients With Peripheral Facial Paralysis